Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Ductal × Tamoxifen × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 254 Carcinoma, Intraductal, Noninfiltrating 24 Breast Carcinoma In Situ 21 Neoplasm Metastasis 12 Breast Neoplasms, Male 12 Neoplasms 11 Ovarian Neoplasms 9 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Prostatic Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Endometrial Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Astrocytoma 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Medulloblastoma 2 Liver Neoplasms 2 Hot Flashes 2 Glioma, Subependymal 2 Fibroadenoma 2

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 exemestane 1 canakinumab 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Doxorubicin 1 Docetaxel 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡